Remedy Entertainment shares a forward-looking view for investors on new projects
Remedy Entertainment, the studio behind Max Payne, Alan Wake, and Control, has published an investor report that outlines upcoming projects and strategic direction. The document confirms several long‑term plans while detailing ongoing development work and milestones across its portfolio.
According to the investor report, Alan Wake II is nearing completion and is scheduled to arrive on major platforms that include PlayStation 5, Xbox Series X/S, and PC. The title is described as a next‑gen experience that leverages Remedy’s narrative emphasis and atmospheric design. On the distribution side, the report notes a PC release through the Epic Games Store in alignment with the company’s platform strategy.
The studio’s broader slate includes Control 2 along with its experimental spinoffs, codenamed Condor and Vanguard. The materials indicate these projects are currently in the proof‑of‑concept phase, where small, playable segments are produced to identify technical challenges and refine core gameplay and storytelling concepts. This phase helps Remedy map risks and craft a concrete development plan before full production begins.
In addition to new experiences, Remedy confirms work on remakes of the first two Max Payne installments. Both remakes are described as being in the concept stage, with teams exploring visual styles, narrative revisions, character updates, and key mechanics to align with contemporary benchmarks while preserving the essence of the originals.
Beyond project updates, the investor report shares performance statistics for Remedy’s released titles. Control has demonstrated solid commercial reach, with several million copies sold and a broad player base that has benefited from promotional campaigns and a subscription model. The company notes that its games have attracted a large and diverse audience, underscoring the impact of Remedy’s ongoing live service and community engagement strategies.
Industry observers have pointed to Remedy’s balanced mix of single‑player storytelling experiences and evolving live service elements as a core strength. The investor document positions this balance as central to the studio’s growth trajectory, highlighting disciplined project evaluation, iterative development cycles, and a clear emphasis on quality, narrative depth, and atmospheric world-building.
Remedy’s leadership also stresses a commitment to innovation and collaboration with publishing partners, aiming to deliver memorable gameplay moments while expanding the studio’s creative footprint across genres and platforms.
Overall, the investor report paints a picture of a studio in a strong development phase, pursuing a slate that blends new narratives, platform versatility, and selective remakes. The approach reflects ongoing efforts to maintain creative vitality while delivering value to players and investors alike.
As reports surface from media outlets and industry watchers, analysts emphasize Remedy’s capacity to align ambitious projects with practical production planning. The company’s transparent communication about milestones, platform strategies, and audience reach helps stakeholders gauge progress and long‑term potential in a competitive market.